A randomised clinical trial evaluating adjuvant chemotherapy with capecitabine compared to expectant treatment alone following surgery for biliary tract cancer.
Aim: To investigate the role of adjuvant chemotherapy with capecitabine following surgical resection of a biliary tract cancer.
BILCAP is an NCRN trial supported by Cancer Research UK.
If you are a Health Care Professional and would like access to the section of the site for Health Care Professionals and/or would like to be considered for participation as a Local Investigator for BILCAP, please contact us at BILCAP@trials.bham.ac.uk
The Clinical Trials Unit at the Cancer Research UK, Institute of Cancer Studies stands comfortably between the Pan Birmingham network of Hospitals that serve a population of over 5,000,000 people and a large basic science research group of over 200 researchers situated at the Institute of Cancer Studies.
